Cargando…

Management and outcomes of chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review protocol

INTRODUCTION: Pneumoperitoneum – free air within the peritoneal cavity – is often the result of bowel perforation, though other causes include residual postprocedural or postoperative air and barotrauma. In non-cancer patients, operative intervention is often required. Cancer patients, on the other...

Descripción completa

Detalles Bibliográficos
Autores principales: Maina, Renee M., Rader, Caroline A., Kypa, Jeevan, Jasmin, Hilary M., Asahngwa, Constantine, Muenyi, Clarisse S., Foretia, Denis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688533/
https://www.ncbi.nlm.nih.gov/pubmed/38045559
http://dx.doi.org/10.1097/SP9.0000000000000007
_version_ 1785152189012901888
author Maina, Renee M.
Rader, Caroline A.
Kypa, Jeevan
Jasmin, Hilary M.
Asahngwa, Constantine
Muenyi, Clarisse S.
Foretia, Denis A.
author_facet Maina, Renee M.
Rader, Caroline A.
Kypa, Jeevan
Jasmin, Hilary M.
Asahngwa, Constantine
Muenyi, Clarisse S.
Foretia, Denis A.
author_sort Maina, Renee M.
collection PubMed
description INTRODUCTION: Pneumoperitoneum – free air within the peritoneal cavity – is often the result of bowel perforation, though other causes include residual postprocedural or postoperative air and barotrauma. In non-cancer patients, operative intervention is often required. Cancer patients, on the other hand, present a unique set of challenges as they usually have elevated risk of pneumoperitoneum from local radiation therapy, frequent endoscopic procedures, and tumor invasion. Factors such as malnutrition, neutropenia, chemotherapy, and steroid use make emergent surgery tenuous in cancer patients. There is a paucity of published literature on the management of pneumoperitoneum in patients actively undergoing chemotherapy. The main objective of this scoping review is to assess the presentation, management, and subsequent outcomes of this unique patient population. MATERIALS AND METHODS: The authors will utilize the framework for performing scoping reviews as outlined by Arksey and O’Malley. They will perform the search for articles in three electronic databases (i.e. SCOPUS, PubMed, Embase) and relevant gray literature. Only articles available in English and published between 1999 and 2022 will be included. Inclusion criteria will be a known diagnosis of cancer, chemotherapy within 6 months of presentation, and imaging confirmation of pneumoperitoneum. Exclusion criteria will be cancer diagnosis at the time of presentation, perforation secondary to cancer itself, and chemotherapy greater than 6 months prior to presentation. A tailored extraction frame to extract relevant information from published articles that meet our inclusion criteria. The data using both descriptive statistics and thematic analysis of the main study questions. ETHICS AND DISSEMINATION: Since the authors will not be collecting primary data, formal ethical approval is not required. They study findings will be disseminated through abstracts, conference presentations, and peer-reviewed publications.
format Online
Article
Text
id pubmed-10688533
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106885332023-12-01 Management and outcomes of chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review protocol Maina, Renee M. Rader, Caroline A. Kypa, Jeevan Jasmin, Hilary M. Asahngwa, Constantine Muenyi, Clarisse S. Foretia, Denis A. Int J Surg Protoc Editorial INTRODUCTION: Pneumoperitoneum – free air within the peritoneal cavity – is often the result of bowel perforation, though other causes include residual postprocedural or postoperative air and barotrauma. In non-cancer patients, operative intervention is often required. Cancer patients, on the other hand, present a unique set of challenges as they usually have elevated risk of pneumoperitoneum from local radiation therapy, frequent endoscopic procedures, and tumor invasion. Factors such as malnutrition, neutropenia, chemotherapy, and steroid use make emergent surgery tenuous in cancer patients. There is a paucity of published literature on the management of pneumoperitoneum in patients actively undergoing chemotherapy. The main objective of this scoping review is to assess the presentation, management, and subsequent outcomes of this unique patient population. MATERIALS AND METHODS: The authors will utilize the framework for performing scoping reviews as outlined by Arksey and O’Malley. They will perform the search for articles in three electronic databases (i.e. SCOPUS, PubMed, Embase) and relevant gray literature. Only articles available in English and published between 1999 and 2022 will be included. Inclusion criteria will be a known diagnosis of cancer, chemotherapy within 6 months of presentation, and imaging confirmation of pneumoperitoneum. Exclusion criteria will be cancer diagnosis at the time of presentation, perforation secondary to cancer itself, and chemotherapy greater than 6 months prior to presentation. A tailored extraction frame to extract relevant information from published articles that meet our inclusion criteria. The data using both descriptive statistics and thematic analysis of the main study questions. ETHICS AND DISSEMINATION: Since the authors will not be collecting primary data, formal ethical approval is not required. They study findings will be disseminated through abstracts, conference presentations, and peer-reviewed publications. Lippincott Williams & Wilkins 2023-09-18 /pmc/articles/PMC10688533/ /pubmed/38045559 http://dx.doi.org/10.1097/SP9.0000000000000007 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Editorial
Maina, Renee M.
Rader, Caroline A.
Kypa, Jeevan
Jasmin, Hilary M.
Asahngwa, Constantine
Muenyi, Clarisse S.
Foretia, Denis A.
Management and outcomes of chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review protocol
title Management and outcomes of chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review protocol
title_full Management and outcomes of chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review protocol
title_fullStr Management and outcomes of chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review protocol
title_full_unstemmed Management and outcomes of chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review protocol
title_short Management and outcomes of chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review protocol
title_sort management and outcomes of chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review protocol
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688533/
https://www.ncbi.nlm.nih.gov/pubmed/38045559
http://dx.doi.org/10.1097/SP9.0000000000000007
work_keys_str_mv AT mainareneem managementandoutcomesofchemotherapyassociatedpneumoperitoneumincancerpatientsascopingreviewprotocol
AT radercarolinea managementandoutcomesofchemotherapyassociatedpneumoperitoneumincancerpatientsascopingreviewprotocol
AT kypajeevan managementandoutcomesofchemotherapyassociatedpneumoperitoneumincancerpatientsascopingreviewprotocol
AT jasminhilarym managementandoutcomesofchemotherapyassociatedpneumoperitoneumincancerpatientsascopingreviewprotocol
AT asahngwaconstantine managementandoutcomesofchemotherapyassociatedpneumoperitoneumincancerpatientsascopingreviewprotocol
AT muenyiclarisses managementandoutcomesofchemotherapyassociatedpneumoperitoneumincancerpatientsascopingreviewprotocol
AT foretiadenisa managementandoutcomesofchemotherapyassociatedpneumoperitoneumincancerpatientsascopingreviewprotocol